Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of Apolipoprotein E Polymorphism with Intravitreal Ranibizumab Treatment Outcomes in Age-Related Macular Degeneration.

Current eye research - 1 Jun 2016

Bakbak Berker, Ozturk Banu Turgut, Zamani Ayşe Gul, Gonul Saban, Iyit Neslihan, Gedik Sansal, Yıldırım M Selman

Abstract excerpt

PURPOSE: Genetic factors are known to influence the response to anti-vascular endothelial growth factor (VEGF) treatment in exudative age-related macular degeneration (AMD). The current study was conducted to investigate the association of Apolipoprotein E (ApoE) polymorphism with the treatment response to ranibizumab for exudative AMD. METHODS: One hundred nine eyes (109 patients, 59.6% male, mean age...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Intravitreal Injections

Share to Treatment Outcome

Share to Vascular Endothelial Growth Factor A

Share to Wet Macular Degeneration

Source

Identifiers

PMID: 26398858
DOI: 10.3109/02713683.2015.1067325

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of Apolipoprotein E Polymorphism with Intravitreal Ranibizumab Treatment Outcomes in Age-Related Macular Degeneration.PMID 26398858Read ↗

VEGF-A polymorphisms predict short-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration.Semantic proximity Read ↗

Association of Apolipoprotein E Polymorphisms with Age-related Macular Degeneration Subtypes: An Updated Systematic Review and Meta-analysis.Semantic proximity Read ↗

Pharmacogenetic association with early response to intravitreal ranibizumab for age-related macular degeneration in a Korean population.Semantic proximity Read ↗

Genetic factors associated with response to intravitreal ranibizumab in Korean patients with neovascular age-related macular degeneration.Semantic proximity Read ↗

Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.Semantic proximity Read ↗

Variants in the APOE gene are associated with improved outcome after anti-VEGF treatment for neovascular AMD.Semantic proximity Read ↗

VEGF gene polymorphism and response to intravitreal ranibizumab in neovascular age-related macular degeneration.Semantic proximity Read ↗

Predictive value of VEGF A and VEGFR2 polymorphisms in the response to intravitreal ranibizumab treatment for wet AMD.Semantic proximity Read ↗

Association between Vascular Endothelial Growth Factor Polymorphisms and Age-Related Macular Degeneration: An Updated Meta-Analysis.Semantic proximity Read ↗

The role of apolipoprotein E (rs7412 and rs429358) in age-related macular degeneration.Semantic proximity Read ↗

Combined effects of genetic and non-genetic risk factors affect response to ranibizumab in exudative age-related macular degeneration.Semantic proximity Read ↗

IL-8 and VEGFR-2 polymorphisms modulate long-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.